Stockreport

Psychiatric disorders treatment developer Pasithea Therapeutics prices upsized IPO at $5 [Seeking Alpha]

Pasithea Therapeutics Corp.  (KTTA) 
PDF Psychiatric disorders treatment developer Pasithea Therapeutics prices upsized IPO at $5 [Read more]